Once-a-day drug regimen for psychiatric patients.
Patient compliance can be improved by reducing the complexity of drug dosage and by better labeling, packaging and informational exchange. Single bedtime doses not only increase compliance but also decrease side effects. The once-a-day regimen can reduce drug automatism and thus decrease acute confusional states, especially in the elderly.
D000328:Adult; D000928:Antidepressive Agents / Q000008:administration & dosage; D014150:Antipsychotic Agents / Q000008:administration & dosage; D001007:Anxiety / Q000188:drug therapy; D003866:Depressive Disorder / Q000188:drug therapy; D004334:Drug Administration Schedule; D004346:Drug Information Services; D004348:Drug Labeling; D004349:Drug Packaging; D004827:Epilepsy / Q000188:drug therapy; D006801:Humans; D008094:Lithium / Q000008:administration & dosage; D001523:Mental Disorders / Q000188:drug therapy*; D010349:Patient Compliance; D010672:Phenytoin / Q000008:administration & dosage; D011433:Propranolol / Q000008:administration & dosage; D011618:Psychotic Disorders / Q000188:drug therapy; D011619:Psychotropic Drugs / Q000008:administration & dosage*
D000928:Antidepressive Agents; D014150:Antipsychotic Agents; D011619:Psychotropic Drugs; D010672:Phenytoin; D008094:Lithium; D011433:Propranolol